Health and Medical Research Fund (HMRF)
List of Abbreviations: here
Health and Medical Research Fund (HMRF)
| Awarded Year | Principal Investigator (PI)/ Project Coordinator (PC) | Project Title |
|---|---|---|
| 2023/24 | Dr Zhang Lu (COMP) | Advancing clinical differentiation between constipation-predominant irritable bowel syndrome and functional constipation using machine learning models |
| 2023/24 | Dr Yin Kejing (COMP) | AI models helping combat antibiotic resistance in ICU – personalized decision support for empirical antibiotic therapy |
| 2023/24 | Dr Lung Hong Lok (CHEM) | The application of the EBV-encoded nuclear antigen 1-targeting bioprobe in nasopharyngeal carcinoma diagnosis |
| 2022/23 | Dr Fung Wai Tung Ada (SPEH) | Effect of a Six-Week Integrated Attention Training Program on the Cognitive Functions of Older Adults with Co-occurring Anxiety Symptoms and Subjective Cognitive Complaints |
| 2022/23 | Dr Zhong Lidan (SCM) | Electro-acupuncture for Long-COVID Neuropsychiatric Symptoms: A Prospective, Randomized Sham-controlled, Double-blinded Clinical Trial |
| 2022/23 | Dr Cheung King-ho (SCM) | Investigate the Therapeutic Potential of Targeting TRPM7 by Carvacrol to Mitigate Alzheimer’s Disease-Associated Neuroinflammation |
| 2022/23 | Professor Yu Zhiling (SCM) | Use of a TCM Formula Comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos as an Adjuvant of Leigongteng Duogan Tablet for Treating Rheumatoid Arthritis |
| 2021/22 | Dr Zhang Shi Ping (SCM) | Diabetes Screening and Monitoring Using Tongue Images and Self-Reported Symptoms: a Machine Learning Approach |
| 2021/22 | Dr Duan Yanping (SPEH) | Effects of a Blended Indoor and Outdoor Physical Exercise Program on Depressive Symptoms in Hong Kong Older Adults: A Randomized Controlled Trial |
| 2021/22 | Dr Zhong Lidan (SCM) | Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-Induced Neurotoxicity in Colorectal Cancer Patients: a Prospective, Randomized, Sham-controlled, Double-blinded and Multicenter Study |
| 2021/22 | Professor Yu Zhiling (SCM) | Ginsenoside Rg3 and Artesunate Synergistically Overcome Sorafenib Resistance in Hepatocellular Carcinoma: Pharmacological Effects and Mechanisms of Action |
| 2021/22 | Dr Tan Hor Yue (SCM) | Investigation on the Promoting Role of Commensal Lactobacillus Species in Pancreatic Cancer Response to Immune Checkpoint Inhibitors |
| 2021/22 | Professor Li Min (SCM) | Natural Small Molecule Isorhamnetin and Its Optimized Derivatives for Parkinson’s Disease Treatment by Targeting TFEB-mediated Autophagy |
| 2021/22 | Dr Fu Xiuqiong (SCM) | Use of Si-Jun-Zi-Tang as an Adjuvant of Temozolomide for Treating Melanoma |
| 2020/21 | Dr Wong Hoi Leong Xavier (SCM) | Investigating the Role of ADAM9 in the Regulation of Body Weight and Food Intake |
| 2020/21 | Dr Fu Xiuqiong (SCM) | Ranunculi Ternati Radix Inhibits STAT3 Signaling Through Upregulating miR-351 to Exert Anti-melanoma Effects |
| 2020/21 | Dr Zhang Xuan (SCM) | Research on Improving the Quality of Multicentre Clinical Trials: Development of the Reporting Guideline |
| 2020/21 | Dr Kwan Hiu Yee (SCM) | WNT974 and Artesunate Exhibit Synergy in Inhibiting Colorectal Cancer Growth by Increasing KRAS Protein Degradation |